EGFR and breast carcinoma: No involvement of MMP-17 in the EMT of HCC was found in the literature, but it was implicated in breast cancer progression, apparently by facilitating in vivo and in vitro breast cancer cell proliferation through outside-in EGFR signaling, but without acting as a protease [79].